1. Home
  2. CCNE vs GERN Comparison

CCNE vs GERN Comparison

Compare CCNE & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$27.10

Market Cap

736.3M

Sector

Finance

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.31

Market Cap

753.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCNE
GERN
Founded
1865
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
736.3M
753.3M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CCNE
GERN
Price
$27.10
$1.31
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$29.00
$3.00
AVG Volume (30 Days)
137.9K
7.8M
Earning Date
01-16-2026
02-25-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$227,923,000.00
$183,403,000.00
Revenue This Year
$13.84
$147.42
Revenue Next Year
$27.68
$37.07
P/E Ratio
$14.19
N/A
Revenue Growth
5.27
522.13
52 Week Low
$19.32
$1.04
52 Week High
$28.04
$3.12

Technical Indicators

Market Signals
Indicator
CCNE
GERN
Relative Strength Index (RSI) 58.61 49.20
Support Level $25.72 $1.28
Resistance Level $26.73 $1.48
Average True Range (ATR) 0.56 0.08
MACD 0.02 -0.01
Stochastic Oscillator 87.50 16.92

Price Performance

Historical Comparison
CCNE
GERN

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: